IL2 and mesothelioma: Human mesothelioma exosomes were shown to alter the way in which immune cells respond to IL-2 by inhibiting IL-2-driven priming of both cytotoxic NK cells and CD8+ T cells, while leaving the IL-2-dependent activation of the immunosuppressive Treg populations unaffected (Figure 3).